Entrada Therapeutics Inc (TRDA)
18.80
+0.75
(+4.16%)
USD |
NASDAQ |
Nov 22, 16:00
18.85
+0.05
(+0.27%)
After-Hours: 20:00
Entrada Therapeutics Stock Buybacks (Quarterly): 0.00 for Sept. 30, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2023 | -19.41M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-19.41M
Minimum
Mar 2023
--
Maximum
Mar 2022
-1.764M
Average
--
Median
Mar 2022
Stock Buybacks (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 0.00 |
| Vertex Pharmaceuticals Inc | 391.40M |
| Assembly Biosciences Inc | 0.00 |
| Sarepta Therapeutics Inc | -- |
| Regenxbio Inc | -0.246M |